Herman Van Oyen

Herman Van Oyen

Auto-generated profile, based on publicly available information

Herman Van Oyen

Lifestyle and chronic diseases, Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2007 in Comptes Rendus. Biologies
Verified
Journal Article
Closed access
JRJean-Marie Robine
Jean-Marie Robine
SCSiu Lan K. Cheung
Siu Lan K. Cheung
SRSophie Le Roy
Sophie Le Roy
HOHerman Van Oyen
Herman Van Oyen
CGClare Griffiths
Clare Griffiths
FHFrançois Richard Herrmann
François Richard Herrmann
Daily numbers of deaths at a regional level were collected in 16 European countries. Summer mortality was analyzed for the reference period 1998–2002 and for 2003. More than 70,000 additional deaths occurred in Europe during the summer 2003. Major distortions occurred in the age distribution of the deaths, but no harvesting effect was observed in the months following August 2003. Global warming constitutes a new health threat in an aged Europe that may be difficult to detect at the country level, depending on its size. Centralizing the count of daily deaths on an operational geographical scale constitutes a priority for Public Health in Europe.

1 April 1999 in The British Journal of Psychiatry
Verified
Journal Article
Closed access
PDF file
MPM. J. Prince
M. J. Prince
FRF. Reischies
F. Reischies
ABA. T. F. Beekman
A. T. F. Beekman
RFR. Fuhrer
R. Fuhrer
CJC. Jonker
C. Jonker
JCJ. R. M. Copeland
J. R. M. Copeland
Background: In an 11-country European collaboration, 14 population-based surveys included 21 724 subjects aged ⩾65 years. Most participating centres used the Geriatric Mental State (GMS), but other measures were also used.Aims: To derive from these instruments a common depression symptoms scale, the EURO–D, to allow comparison of risk factor profiles between centres.Method: Common items were identified from the instruments. Algorithms for fitting items to GMS were derived by observation of item correspondence or expert opinion. The resulting 12-item scale was checked for internal consistency, criterion validity and uniformity of factor-analytic profile.Results: The EURO–D is internally consistent, capturing the essence of its parent instrument. A two-factor solution seemed appropriate: depression, tearfulness and wishing to die loaded on the first factor (affective suffering), and loss of interest, poor concentration and lack of enjoyment on the second (motivation)Conclusions: The EURO–D scale should permit valid comparison of risk-factor associations between centres, even if between-centre variation remains difficult to attribute.

28 February 2005 in International Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
JDJaa Dalstra
Jaa Dalstra
AKAe Kunst
Ae Kunst
CBCarme Borrell
Carme Borrell
EBE Breeze
E Breeze
ECE Cambois
E Cambois
JMJp Mackenbach
Jp Mackenbach
Background Few studies have compared socioeconomic inequalities in the prevalence of both fatal and non-fatal diseases. This paper aims to give the first international overview for several common chronic diseases. Methods Micro-level data were pooled from non-standardized national health surveys conducted in eight European countries in the 1990s. Surveys ranged in size from 3700 to 41 200 participants. The prevalence of 17 chronic disease groups were analysed in relation to education. Standardized prevalence rates and age-adjusted odds ratios (ORs) were calculated. Results Most diseases showed higher prevalence among the lower education group. Stroke, diseases of the nervous system, diabetes, and arthritis displayed relatively large inequalities (OR > 1.50). No socioeconomic differences were evident for cancer, kidney diseases, and skin diseases. Allergy was more common in the higher education group. Relative socioeconomic differences were often smaller among the 60–79 age group as compared with the 25–59 age group. Cancer was more prevalent among the lower educated in the 25–59 age group, but among the higher educated in the 60–79 age group. For diabetes, hypertension, and heart disease, socioeconomic differences were larger among women as compared with men. Inequalities in heart disease were larger in northern European countries as compared with southern European countries. Conclusion There are large variations between chronic diseases in the size and pattern of socioeconomic differences in their prevalence. The large inequalities that are found for some specific fatal diseases (e.g. stroke) and non-fatal diseases (e.g. arthritis) require special attention in equity-oriented research and policies.

2 January 2015 in BMC Medical Research Methodology
Verified
Journal Article
Open access
PDF file
NBNicolas Berger
Nicolas Berger
HOHerman Van Oyen
Herman Van Oyen
ECEmmanuelle Cambois
Emmanuelle Cambois
TFTony Fouweather
Tony Fouweather
CJCarol Jagger
Carol Jagger
JRJean-Marie Robine
Jean-Marie Robine
The Global Activity Limitation Indicator (GALI), the measure underlying the European indicator Healthy Life Years (HLY), is widely used to compare population health across countries. However, the comparability of the item has been questioned. This study aims to further validate the GALI in the adult European population. Data from the European Health Interview Survey (EHIS), covering 14 European countries and 152,787 individuals, were used to explore how the GALI was associated with other measures of disability and whether the GALI was consistent or reflected different disability situations in different countries. When considering each country separately or all combined, we found that the GALI was significantly associated with measures of activities of daily living, instrumental activity of daily living, and functional limitations (P < 0.001 in all cases). Associations were largest for activity of daily living and lowest though still high for functional limitations. For each measure, the magnitude of the association was similar across most countries. Overall, however, the GALI differed significantly between countries in terms of how it reflected each of the three disability measures (P < 0.001 in all cases). We suspect cross-country differences in the results may be due to variations in: the implementation of the EHIS, the perception of functioning and limitations, and the understanding of the GALI question. The study both confirms the relevance of this indicator to measure general activity limitations in the European population and the need for caution when comparing the level of the GALI from one country to another.

1 December 2008 in The Lancet
Verified
Journal Article
Closed access
CJCarol Jagger
Carol Jagger
CGClare Gillies
Clare Gillies
FMFrancesco Moscone
Francesco Moscone
ECEmmanuelle Cambois
Emmanuelle Cambois
HOHerman Van Oyen
Herman Van Oyen
JRJean-Marie Robine
Jean-Marie Robine

22 April 2014 in International Journal of Public Health
Verified
Journal Article
Closed access
PDF file
BDBrecht Devleesschauwer
Brecht Devleesschauwer
AHArie H. Havelaar
Arie H. Havelaar
CNCharline Maertens de Noordhout
Charline Maertens de Noordhout
JHJuanita A. Haagsma
Juanita A. Haagsma
NPNicolas Praet
Nicolas Praet
NSNiko Speybroeck
Niko Speybroeck